MA47495A - ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS - Google Patents

ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS

Info

Publication number
MA47495A
MA47495A MA047495A MA47495A MA47495A MA 47495 A MA47495 A MA 47495A MA 047495 A MA047495 A MA 047495A MA 47495 A MA47495 A MA 47495A MA 47495 A MA47495 A MA 47495A
Authority
MA
Morocco
Prior art keywords
iraq
compositions including
jak inhibitors
inflammatory compositions
inflammatory
Prior art date
Application number
MA047495A
Other languages
French (fr)
Inventor
David Amantini
Reginald Christophe Xavier Brys
Philippe Clément-Lacroix
Vos Steve Irma Joel De
René Alexandre Galien
Original Assignee
Galapagos Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos Nv filed Critical Galapagos Nv
Publication of MA47495A publication Critical patent/MA47495A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA047495A 2017-02-17 2018-02-15 ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS MA47495A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1702603.0A GB201702603D0 (en) 2017-02-17 2017-02-17 Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
MA47495A true MA47495A (en) 2019-12-25

Family

ID=58486866

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047495A MA47495A (en) 2017-02-17 2018-02-15 ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS

Country Status (13)

Country Link
EP (1) EP3582775A1 (en)
JP (1) JP2020507612A (en)
KR (1) KR20190117672A (en)
CN (1) CN110300586A (en)
AU (1) AU2018221761A1 (en)
BR (1) BR112019016949A2 (en)
CA (1) CA3054652A1 (en)
GB (1) GB201702603D0 (en)
MA (1) MA47495A (en)
MX (1) MX2019009658A (en)
PH (1) PH12019501853A1 (en)
SG (1) SG11201907492TA (en)
WO (1) WO2018149925A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019111218A1 (en) 2017-12-08 2019-06-13 Cadila Healthcare Limited Novel heterocyclic compounds as irak4 inhibitors
CN113713083A (en) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 Pharmaceutical composition for treating alopecia
CN115843296B (en) 2020-08-07 2024-03-08 南京迈晟科技有限责任公司 CDK9 inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3041B1 (en) 2008-07-25 2016-09-05 Galapagos Nv Novel compounds useful for the treatment of degenerative and inflammatory diseases
TWI462920B (en) 2009-06-26 2014-12-01 葛萊伯格有限公司 Novel compound useful for the treatment of degenerative and inflammatory diseases
CA2875619C (en) 2012-06-22 2020-11-24 Galapagos Nv Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
GB201402071D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201402070D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Pharmaceutical compositions for the treatment of inflammatory disorders
GB201518456D0 (en) * 2015-10-19 2015-12-02 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory, autoimmune and/or proliferative diseases
US20170173034A1 (en) * 2015-12-17 2017-06-22 Gilead Sciences, Inc. Combination of a jak inhibitor and a syk inhibitor for treating cancers and inflammatory disorders

Also Published As

Publication number Publication date
BR112019016949A2 (en) 2020-05-26
MX2019009658A (en) 2019-10-02
AU2018221761A1 (en) 2019-10-03
WO2018149925A1 (en) 2018-08-23
EP3582775A1 (en) 2019-12-25
CA3054652A1 (en) 2018-08-23
PH12019501853A1 (en) 2020-06-15
KR20190117672A (en) 2019-10-16
SG11201907492TA (en) 2019-09-27
CN110300586A (en) 2019-10-01
JP2020507612A (en) 2020-03-12
GB201702603D0 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
DK3565550T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM AND RIZATRIPTANE
MA46427A (en) COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES
DK3478811T3 (en) Cleaning compositions and uses thereof
MA44991A (en) POLYTHERAPIES OF HDAC INHIBITORS AND PD-1 INHIBITORS
MA44990A (en) POLYTHERAPIES OF HDAC INHIBITORS AND PD-L1 INHIBITORS
DK3600364T3 (en) COMPOSITIONS INCLUDING A BACTERIA TRACT OF THE GENEAL MEGASPHAERA GENERAL AND USES THEREOF
MA45270A (en) COMPOSITIONS OF OLIGONUCLEOTIDES AND RELATED PROCESSES
MA48797A (en) CBLB ENDONUCLEASE VARIANTS, COMPOSITIONS AND METHODS OF USE
DK3890488T3 (en) HERBICIDE COMPOSITIONS
MA52004A (en) O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLYCOPYRANOSIDASE INHIBITORS
MA43361A (en) COMPOSITION FOR THE CARE AND PROTECTION OF CROPS
FR3056393B1 (en) ORTHESIS OF EXTENSION OF JAWS
MA49006A (en) IP6K INHIBITORS
DK3595667T3 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING A JAK INHIBITOR
MA47203A (en) NHE-MEDIATION ANTIPORT INHIBITORS
MA43806A (en) SPRAY COATED FERTILIZER COMPOSITION
MA47495A (en) ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS
DK3403674T3 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PAIN
IL276352A (en) Quinoline compounds as irak inhibitors and uses thereof
ZA202008034B (en) Ivosidenib forms and pharmaceutical compositions
IT201900020514A1 (en) IRRIGATION AND / OR FERTIGATION DEVICE
IT201900004805A1 (en) ANTIPPIRANT AND DEODORANT COMPOSITIONS
DK3601450T3 (en) COATING COMPOSITION AND USE THEREOF
GB201807576D0 (en) Compositions and uses thereof
GB201812334D0 (en) Compositions and uses thereof